SEC CIK 1245624
HEALY JAMES
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| SYBXview stock → | 2,974,811 | 2015-10-06 |
| ACRSview stock → | 2,289,480 | 2015-10-13 |
| AMRNview stock → | 90,000 | 2012-08-31 |
| CHRSview stock → | 0 | 2021-09-29 |
Position History — CHRS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CHRS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2022-01-07 | Grant / award (derivative) | 27,000 | $0.00 | 27,000 |
| 2022-01-07 | Grant / award (derivative) | 27,000 | $0.00 | 27,000 |
| 2021-09-29 | Open-market sale | 286,076 | $16.12 | 0 |
| 2021-09-28 | Open-market sale | 48,329 | $17.17 | 286,076 |
| 2021-09-27 | Open-market sale | 100,150 | $18.06 | 334,405 |
| 2021-01-11 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2020-09-29 | J | 950,000 | $0.00 | 0 |
| 2020-09-29 | J | 213,546 | $0.00 | 434,555 |
| 2020-08-28 | J | 221,009 | $0.00 | 221,009 |
| 2020-08-28 | J | 983,221 | $0.00 | 950,000 |
| 2020-01-12 | Option exercise (derivative) | 20,000 | $0.00 | 0 |
| 2020-01-12 | Option exercise | 20,000 | $12.37 | 70,086 |
| 2020-01-10 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2020-01-09 | Option exercise (derivative) | 29,994 | $0.00 | 0 |
| 2020-01-09 | Option exercise | 29,994 | $1.67 | 30,086 |
| 2020-01-09 | Option exercise | 20,000 | $10.05 | 50,086 |
| 2019-07-02 | Open-market sale | 160,000 | $22.61 | 1,933,221 |
| 2019-06-28 | Open-market sale | 200,000 | $22.05 | 2,093,221 |
| 2019-06-20 | Open-market sale | 317,130 | $21.37 | 2,293,221 |
| 2019-05-22 | Open-market sale | 257,870 | $20.69 | 2,610,351 |
| 2019-01-11 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2018-08-29 | Open-market sale | 25,000 | $20.50 | 2,868,221 |
| 2018-02-01 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2017-05-17 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2016-05-24 | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2015-04-01 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2015-04-01 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2015-04-01 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2015-04-01 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2015-03-18 | J | 33 | $0.00 | 92 |
| 2015-03-18 | J | 239,364 | $0.00 | 2,893,221 |
| 2015-03-18 | J | 239,364 | $0.00 | 2,893,221 |
| 2015-03-18 | J | 33 | $0.00 | 92 |
| 2015-03-10 | J | 96,098 | $0.00 | 2,653,857 |
| 2015-03-10 | J | 12 | $0.00 | 59 |
| 2015-03-10 | J | 96,098 | $0.00 | 2,653,857 |
| 2015-03-10 | J | 12 | $0.00 | 59 |
| 2014-11-12 | Conversion (derivative) | 149,970 | — | 0 |
| 2014-11-12 | Conversion (derivative) | 47 | — | 0 |
| 2014-11-12 | Open-market buy | 425,926 | $13.50 | 2,557,759 |
| 2014-11-12 | Conversion | 149,970 | — | 2,131,833 |
| 2014-11-12 | Conversion | 1,846,890 | — | 1,981,863 |
| 2014-11-12 | Conversion | 47 | — | 47 |
| 2014-11-06 | — | — | — | 134,973 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.